Roles v. the Boeing Co.

230 P.3d 771, 43 Kan. App. 2d 619, 2010 Kan. App. LEXIS 45
CourtCourt of Appeals of Kansas
DecidedApril 15, 2010
Docket102,307
StatusPublished
Cited by2 cases

This text of 230 P.3d 771 (Roles v. the Boeing Co.) is published on Counsel Stack Legal Research, covering Court of Appeals of Kansas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Roles v. the Boeing Co., 230 P.3d 771, 43 Kan. App. 2d 619, 2010 Kan. App. LEXIS 45 (kanctapp 2010).

Opinion

Pierron, J.:

The Boeing Company and Insurance Company of the State of Pennsylvania (Boeing) appeal the March 30, 2009, order of the Workers Compensation Board (Board). Boeing argues that the Board erred in ordering a final award of $106,339.65 in medical compensation to Karen C. Roles. In addition, Boeing argues that the Board erred in awarding Roles post-award medical benefits for expenses incurred outside of the 6-month relation back period delineated in K.S.A. 2009 Supp. 44-510k.

Roles began working for Boeing on January 21, 1975. While working for Boeing, Roles has had a long history of respiratory problems. In 1979, she was diagnosed with bronchiectasis. Surgery was required, and Roles underwent a left lower lobectomy. Despite the surgery, Roles required numerous inpatient and outpatient medical treatments for respiratory problems throughout the 1980’s and 1990’s. As a result of these continuing problems, Roles was taken off work from 1991-1996.

On February 22, 1995, Roles settled a claim for workers compensation benefits against Boeing. As a result of this settlement, premised upon an allegation of occupationally induced asthma, Boeing paid Roles a lump sum of $61,500, as well as $63,494 in *620 temporary total disability benefits (228 weeks). In addition, Boeing paid Roles’ medical expenses in the amount of $76,680.34. Under the terms of the settlement agreement, Roles waived her right to any future medical compensation.

While Roles was off work, her respiratory symptoms improved. As a consequence of these improvements, she was released to work in a smoke-, chemical-, and odor-free environment not involving physical labor. On May 10, 1996, Roles returned to work with Boeing as a lead person in Industrial Park Building-3 (IPB-3).

In 1997, Roles moved to a different area of IPB-3, where she was exposed to chemicals contained in cleaning solvents and fumes from mini-riveters. In 2000, she was moved to Industrial Park Building-1 (IPB-1), which lacked air conditioning and was overcrowded with employees and machines.

In 1999, Roles started developing upper respiratory problems, with irritation in her throat and upper chest area. After seeking medical treatment, Roles was tentatively diagnosed with vocal cord dysfunction as well as asthma, gastroesophageal reflux, and rhino sinusitis. Roles continued to receive medical treatment until at least 2001.

On June 30, 2001, Roles took a medical leave of absence from Boeing to obtain carpal tunnel release surgery. She returned on July 16, 2001, and worked until July 18, 2001. On July 18, 2001, Roles again began having breathing problems. Roles’ last day of work was July 18, 2001. She was unable to return because of her respiratory problems. After July 18, 2001, Roles continued to require hospitalization and medical treatment for these respiratory problems. Ultimately, she was diagnosed with interstitial lung disease and has significant fibrosis of the lungs. As a consequence, Roles is completely disabled from work and has lung function of approximately 20%.

In September 2001, Roles filed an application for a preliminary hearing to determine the compensability of her exposure to chemicals and contaminants in her work environment at Boeing as of July 16, 2001, and each day worked thereafter. In April 2002, the administrative law judge (ALJ) held a prehminary hearing to consider Roles’ claim for workers compensation benefits. The ALJ *621 denied Roles’ claim after finding that her vocal cord dysfunction was a new injury that arose after her 1995 setdement with Boeing but that the injury was not compensable because there was no toxological link between Roles’ injury and her work environment. After the denial of her claim, Roles timely filed an application for review.

In October 2002, the Board reversed the ALJ’s preliminaiy hearing order. The Board agreed that Roles suffered a new and separate injury of vocal cord dysfunction after her February 1995 settlement agreement. However, contrary to the ALJ, the Board found that the vocal cord dysfunction was caused by Roles’ exposure to chemical irritants in the workplace. As a consequence, the Board ordered Boeing to “pay as authorized medical treatment all reasonable and necessary medical expenses, in accordance with the medical fee schedule, incurred since July 18, 2001, for the treatment of Roles’ work-related respiratory injuries.” Pursuant to the Board’s preliminary order, Boeing paid Roles’ medical expenses in the amount of $106,339.65.

After lengthy prehminary proceedings, the ALJ held a final award hearing in November 2005. At the hearing, Roles testified regarding her employment with Boeing as well as her medical history. However, she never testified or introduced evidence regarding the bills submitted under the prehminary hearing order or their relation to her ihness. Deposition testimony of Dr. Allen J. Parmet, who independently evaluated Roles’ medical records, also confirmed that a few medical expenses submitted for payment by Boeing were unrelated to her occupational exposure at Boeing.

On October 30, 2006, the ALJ entered its final award finding that Roles had suffered a new chemical exposure through her last day worked at Boeing, July 18, 2001. As a result of that exposure, the ALJ found that she was permanently and totally disabled. Although the ALJ’s award noted that Boeing had paid Roles’ medical expenses in the amount of $106,339.65, for some unknown reason the ALJ made no further ruling regarding the compensability of these expenses. As to Roles’ eligibility for future medical expenses, the ALJ ordered that Roles could only be awarded future medical *622 benefits “upon proper application to and approval by the Director of the Division of Workers Compensation.”

After the ALJ’s final award, both Roles and Boeing timely filed applications for review to the Board. In April 2007, the Board issued an order confirming that Roles was permanently and totally disabled from any type of employment. As to the compensability of Roles’ medical expenses, the Board remanded the matter to the ALJ for consideration of “whether the incurred medical bills are related to any chemical exposure, and more specifically, whether the bills were reasonable and necessary to cure and reheve claimant from the effects of her injuries suffered while in respondent’s employment.”

Pursuant to the Board’s directive, the ALJ held a remand hearing in July 2007. Although the Board’s order only permitted the ALJ to consider the record presented at the final award hearing, the ALJ permitted Roles, over Boeing’s objection, to testify regarding tire submitted medical expenses.

During this hearing, Roles testified that most of the bills submitted to Boeing for payment were related to her lung and respiratory exposure. However, she had not brought the medical bills to the hearing for examination and, therefore, could not conclusively testify that the bills submitted to Boeing did not include bills for unrelated medical expenses. During the course of her testimony, Roles admitted with certainty that at least one bill, a charge for a pap smear, was unrelated to her occupational exposure and agreed to remove it from consideration.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Jennings v. T Rowe Pipe
Court of Appeals of Kansas, 2020
Morales v. Transwood, Inc.
Court of Appeals of Kansas, 2017
Hoesli v. Triplett, Inc. (
321 P.3d 18 (Court of Appeals of Kansas, 2014)

Cite This Page — Counsel Stack

Bluebook (online)
230 P.3d 771, 43 Kan. App. 2d 619, 2010 Kan. App. LEXIS 45, Counsel Stack Legal Research, https://law.counselstack.com/opinion/roles-v-the-boeing-co-kanctapp-2010.